Assessment of Adverse Events in Protocols, Clinical Study Reports, and Published Papers of Trials of Orlistat: A Document Analysis.
Schroll, Jeppe Bennekou; Penninga, Elisabeth I; Gøtzsche, Peter C.
; 13(8): e1002101, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27529343
Drug interventions for the treatment of obesity in children and adolescents.
Weight reduction for non-alcoholic fatty liver disease.
Interventions for treating obesity in children.
Long-term effects of weight-reducing drugs in people with hypertension.
Long-term pharmacotherapy for obesity and overweight.
Dose-ranging study of an orlistat tablet formulation.
In vitro antioxidant and reducing capability of weight loss tablet formulation.
Estudio de la prevalencia del sobrepeso y la obesidad en un centro penitenciario español
Treatment of obesity with celastrol.